Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 16901391)

1.

Adjuvant Therapy for Stage II Colorectal Cancer: Who and with What?

Chung KY, Kelsen D.

Curr Treat Options Gastroenterol. 2006 Jun;9(3):272-80.

PMID:
16901391
2.

Views of Australian Medical Oncologists Regarding the Use of Mismatch Repair Status to Assist Adjuvant Chemotherapy Recommendations for Patients With Early-Stage Colon Cancer.

Loh KW, Michael M, Zalcberg JR, Jefford M.

Clin Colorectal Cancer. 2015 Apr 1. pii: S1533-0028(15)00037-7. doi: 10.1016/j.clcc.2015.03.001. [Epub ahead of print]

PMID:
26002619
3.

Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients.

Dienstmann R, Salazar R, Tabernero J.

J Clin Oncol. 2015 Jun 1;33(16):1787-1796. Epub 2015 Apr 27. Review.

PMID:
25918287
4.

Adjuvant therapy of stage III colon cancer.

Sun W, Haller DG.

Chin Clin Oncol. 2013 Jun;2(2):17. doi: 10.3978/j.issn.2304-3865.2013.06.03.

5.

Stage II colon cancer.

Church DN, Midgley R, Kerr DJ.

Chin Clin Oncol. 2013 Jun;2(2):16. doi: 10.3978/j.issn.2304-3865.2013.03.03.

6.

Adjuvant chemotherapy and prognostic factors in stage II colon cancer--Izmir Oncology Group Study.

Kucukzeybek Y, Dirican A, Demir L, Yildirim S, Akyol M, Yildiz Y, Bayoglu IV, Alacacioglu A, Varol U, Salman T, Yildiz I, Can H, Tarhan MO.

Asian Pac J Cancer Prev. 2015;16(6):2413-8.

7.

Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.

Kopetz S, Tabernero J, Rosenberg R, Jiang ZQ, Moreno V, Bachleitner-Hofmann T, Lanza G, Stork-Sloots L, Maru D, Simon I, Capellà G, Salazar R.

Oncologist. 2015 Feb;20(2):127-33. doi: 10.1634/theoncologist.2014-0325. Epub 2015 Jan 5.

PMID:
25561511
8.

A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer.

Lindskog EB, Gunnarsdóttir KÁ, Derwinger K, Wettergren Y, Glimelius B, Kodeda K.

BMC Cancer. 2014 Dec 13;14:948. doi: 10.1186/1471-2407-14-948.

9.

Effect of muscle mass on toxicity and mortality in patients with colon cancer undergoing adjuvant chemotherapy.

Jung H, Kim JW, Kim SW, Kim JH.

J Geriatr Oncol. 2014 Jul;5 Suppl 1:S12. doi: 10.1016/j.jgo.2014.06.027. Epub 2014 Jul 3. No abstract available.

PMID:
25063614
10.

Gastrointestinal tract obstruction due to jejunal adenocarcinoma--case report.

Duchnik M, Kaseja K, Gręda J, Kowalewski B.

Pol Przegl Chir. 2014 Apr;86(4):198-201. doi: 10.2478/pjs-2014-0036.

PMID:
24988236
11.

Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer.

Wong AC, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO Jr, Goodman KA, Keating NL.

J Oncol Pract. 2014 Sep;10(5):e360-7. doi: 10.1200/JOP.2013.001309. Epub 2014 Jul 1.

12.

Is a Microsatellite Instability Still Useful for Tailored Treatment in Stage II and III Colon Cancer?

Kim NK.

Ann Coloproctol. 2014 Feb;30(1):5-6. doi: 10.3393/ac.2014.30.1.5. No abstract available.

13.

Stage III Colon Cancer: What Works, What Doesn't and Why, and What's Next.

André T, O'Neil BH, Meyerhardt JA.

Am Soc Clin Oncol Educ Book. 2012:223-30. doi: 10.14694/EdBook_AM.2012.32.223.

14.
15.

Personalized medicine in the adjuvant chemotherapy of stage II colon cancer--are we there yet?

Lee JJ, Chu E.

Oncology (Williston Park). 2013 Aug;27(8):754, 756-8. No abstract available.

16.

Use of molecular biomarkers to inform adjuvant therapy for colon cancer.

Mettu NB, Hurwitz H, Hsu DS.

Oncology (Williston Park). 2013 Aug;27(8):746-54.

17.

Status of targeted therapies in the adjuvant treatment of colon cancer.

Nelson VM, Benson AB 3rd.

J Gastrointest Oncol. 2013 Sep;4(3):245-52. doi: 10.3978/j.issn.2078-6891.2013.035.

18.

Approach to the older patient with stage II/III colorectal cancer: who should get curative-intent therapy?

Ramsdale E, Sanoff H, Muss H.

Am Soc Clin Oncol Educ Book. 2013:163-8. doi: 10.1200/EdBook_AM.2013.33.163.

19.

Gene Expression Profiling for Predicting Outcomes in Stage II Colon Cancer [Internet].

Black ER, Falzon L, Aronson N.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Dec.

20.

Counterpoint: Adjuvant therapy in stage II colon cancer: pain not justified by the gain.

Van Loon K, Venook AP.

J Natl Compr Canc Netw. 2012 Nov 1;10(11):1379-86.

PMID:
23138166
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk